Hypertrophic cardiomyopathy (HCM) characterized by asymmetric ventricular septal hypertrophy, is the commonest cause of sudden cardiac death (SCD) in the young. The underlying etiology of HCM in the childhood and adolescent patients is diverse. Moreover, the prognosis of pediatric HCM depends on the age of presentation and etiology. Despite the complexity of children with obstructive HCM, surgical treatment results in a favorable outcome for carefully selected patients in experienced tertiary referral center in contemporary era. Implantable cardioverter-defibrillator (ICD) remains the most effective and reliable treatment to prevent SCD. New pediatric SCD risk prediction model, which has good discrimination and calibration and can distinguish patients who are most benefit from an ICD implantation, is expected to be further refined in the future.
MaronBJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med2018; 379: 655–668.
2.
RuppSFelimbanMSchanzerA, et al.Genetic basis of hypertrophic cardiomyopathy in children. Clin Res Cardiol2019; 108: 282–289.
3.
Ostman-SmithIWettrellGKeetonB, et al.Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy. Eur Heart J2008; 29: 1160–1167.
4.
NugentAWDaubeneyPEChondrosP, et al.Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation2005; 112: 1332–1338.
5.
MaronBJOmmenSRSemsarianC, et al.Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol2014; 64: 83–99.
6.
JensenMKHavndrupOChristiansenM, et al.Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation2013; 127: 48–54.
7.
SemsarianCInglesJMaronMS, et al.New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol2015; 65: 1249–1254.
8.
LipshultzSESleeperLATowbinJA, et al.The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med2003; 348: 1647–1655.
9.
PE DAWN and, et al.PC. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med2003; 348: 1639–1646.
10.
ArolaAJokinenERuuskanenO, et al.Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol1997; 146: 385–393.
11.
MalcićIJelusićMKniewaldH, et al.Epidemiology of cardiomyopathies in children and adolescents: a retrospective study over the last 10 years. Cardiol Young2002; 12: 253–259.
12.
ElliottPMAnastasakisABorgerMA, et al.2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J2014; 35: 2733–2779.
13.
ColanSDLipshultzSELoweAM, et al.Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry. Circulation2007; 115: 773–781.
14.
NorrishGFieldEMcLeodK, et al.Clinical presentation and survival of childhood hypertrophic cardiomyopathy: a retrospective study in United Kingdom. Eur Heart J2019; 40: 986–993.
15.
MauriziNPassantinoSSpazianiG, et al.Long-term outcomes of pediatric-onset hypertrophic cardiomyopathy and age-specific risk factors for lethal arrhythmic events. JAMA Cardiol2018; 3: 520–525.
16.
AlexanderPMANugentAWDaubeneyPEF, et al.Long-term outcomes of hypertrophic cardiomyopathy diagnosed during childhood: results from a national population-based study. Circulation2018; 138: 29–36.
17.
LipshultzSEOravEJWilkinsonJD, et al.Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the pediatric cardiomyopathy registry. Lancet2013; 382: 1889–1897.
18.
WangSCuiHYuQ, et al.Excision of anomalous muscle bundles as an important addition to extended septal myectomy for treatment of left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg2016; 152: 461–468.
19.
ZhuCWangSMaY, et al.Childhood hypertrophic obstructive cardiomyopathy and its relevant surgical outcome. Ann Thorac Surg2020; 110: 207–213.
20.
OmmenSRMitalSBurkeMA, et al.2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol2020; 76: e159–e240.
DesaiMYBhonsaleASmediraNG, et al.Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction. Circulation2013; 128: 209–216.
23.
IacovoniASpiritoPSimonC, et al.A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy. Eur Heart J2012; 33: 2080–2087.
24.
McLeodCJOmmenSRAckermanMJ, et al.Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J2007; 28: 2583–2588.
25.
WooAWilliamsWGChoiR, et al.Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation2005; 111: 2033–2041.
26.
OmmenSRMaronBJOlivottoI, et al.Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol2005; 46: 470–476.
27.
SchleihaufJCleuziouJvon OhainJP, et al.Clinical long-term outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in infants. Eur J Cardiothorac Surg2018; 53: 538–544.
28.
QuintanaEJohnsonJNSabate RotesA, et al.Surgery for biventricular obstruction in hypertrophic cardiomyopathy in children and young adults: technique and outcomes. Eur J Cardiothorac Surg2015; 47: 1006–1012. DOI: 10.1093/ejcts/ezu313
29.
AltarabshehSEDearaniJABurkhartHM, et al.Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults. Ann Thorac Surg2013; 95: 663–669; discussion 669.
30.
Walter EMDSiniawskiHHetzerR. Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children. Eur J Cardiothorac Surg2009; 36: 546–552.
31.
TheodoroDADanielsonGKFeldtRH, et al.Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg1996; 112: 1589–1597; discussion 1597–1589.
32.
NorrishGDingTFieldE, et al.Development of a novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids). JAMA Cardiol2019; 4: 918–927. DOI: 10.1001/jamacardio.2019.2861
33.
MaronBJSpiritoPAckermanMJ, et al.Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol2013; 61: 1527–1535.
34.
O'MahonyCJichiFPavlouM, et al.A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J2014; 35: 2010–2020.
